: A steady healthcare choice that is spinning off its diabetes unit to focus on higher-margin medical device sales. 3. Undervalued & Sector-Specific Opportunities
: Highlighted as a "Strong Buy" by Zacks and others for its custom AI chips and networking business, with semiconductor revenue projected to triple by 2027.
: Viewed as a classic defensive holding with 69 years of dividend growth, currently undergoing restructuring to boost productivity. what stock should i buy
: A top defensive pick with over 50 years of dividend increases, benefiting from tech-driven e-commerce and its high-margin advertising business.
: As the world's leading foundry, it is seen by The Motley Fool as a resilient winner with an estimated 20% upside over the next year. : A steady healthcare choice that is spinning
: Remains a top choice for 2026, with analysts at U.S. News forecasting 61% revenue growth in fiscal 2027 driven by AI and edge device expansion.
Analysts at Morningstar and Forbes have identified several stocks trading below their estimated fair value. NASDAQ:NVDA : Viewed as a classic defensive holding with
: Currently the "most upgraded stock of 2026" due to a shortage of high-bandwidth memory (HBM) used in AI data centers. 2. Stability & Defensive Income